Thinking translational: Things to consider in CAR T cell research workflows

Developing safe and effective CAR T cell therapies is a challenging task. That’s why thinking translational early in research experiments is important. Suitable tools will later enable a smooth transition from small-scale to large-scale workflows.

Join us as we discuss how to set up your small-scale research workflow to ease up the transition to large-scale manufacturing in preclinical development.

Learn about key considerations for every step of your workflow including cell separation, culture, and analysis
Get to know solutions specially developed for a smooth transition to cell manufacturing
What´s new? – Latest developments for CAR T cell research and manufacturing

Saskia Rösch, PhD

Global Product Manager, Miltenyi Biotec

Saskia Rösch, PhD, received her doctoral degree in Biology from the University of Heidelberg/DKFZ, Germany, in 2017. She continued her studies in Cancer Immunotherapy as a postdoctoral fellow at the University Hospital in Heidelberg, Germany, before joining Miltenyi Biotec as a Global Product Manager for T Cell Immunology and Gene-engineered T cells.